Picture Swiss Biotech Association LSG Swiss Biotech Days 2025 Basel 650x100px

Organisation › Details

Boehringer Ingelheim KG

https://www.boehringer.com

	Start	1885-01-01 established
	End	1998-01-01 renamed
	Group	Boehringer Ingelheim (Group)
	Today	Boehringer Ingelheim Pharma KG
	Successor	Boehringer Ingelheim Pharma KG
	Industry	pharmaceutical

	Region	Ingelheim
	Country	Germany
	City	55216 Ingelheim
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2025-03-16

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Boehringer Ingelheim (Group)

[1] Tessellate Bio B.V.. (4/23/25). "Press Release: Boehringer Ingelheim and Tessellate Bio Partner to Develop First-in-class Precision Treatments for People with Hard-to-treat Cancers". Ingelheim & Amsterdam....
[2] Boehringer Ingelheim. (4/3/25). "Press Release: Boehringer Ingelheim Strengthens Antibody-Drug Conjugate Portfolio with New NBE Therapeutics R&D Center in Basel". Basel....
[3] Boehringer Ingelheim. (4/2/25). "Press Release: Boehringer Ingelheim Reaches more Patients in 2024 and Prepares New Medicine Launches". Ingelheim....
[4] Salipro Biotech AB. (3/13/25). "Press Release: Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs". Stockholm....
[5] Veeva Systems Inc.. (3/11/25). "Press Release: Boehringer Ingelheim Partners with Veeva to Launch ‘One Medicine Platform’". Ingelheim & Pleasonton, CA....
[6] Boehringer Ingelheim. (3/4/25). "Press Release: Boehringer Ingelheim Enhances Biopharmaceutical Contract Manufacturing Services in China". Ingelheim....
[7] Boehringer Ingelheim. (2/20/25). "Press Release: Boehringer Ingelheim and Partners Start Clinical Development of a First-in-Class, Inhaled Gene Therapy for People with Cystic Fibrosis". Ingelheim....
[8] Boehringer Ingelheim. (1/16/25). "Press Release: Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia". Ingelheim....
[9] Boehringer Ingelheim. (1/9/25). "Press Release: Boehringer Ingelheim Broadens Oncology Portfolio with License for Synaffix’s ADC Technology". Amsterdam, Basel & Ingelheim....
[10] Boehringer Ingelheim. (10/9/24). "Press Release: Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment". Ingelheim & South San Francisco, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)